Drugs Made In America Acquisition II Corp. SEC filings DMII

Drugs Made In America Acquisition II Corp. has 45 filings in SEC EDGAR's recent list, going back to Mar 19, 2025. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Apr 28, 2026 (material agreement). The company's fiscal year ends on December 31.

Drugs Made In America Acquisition II Corp. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Apr 28, 2026 Apr 22, 2026
8-K Current report
Material agreement, New debt
Apr 3, 2026 Mar 24, 2026
8-K Current report
Material agreement, New debt, Other events
Mar 17, 2026 Mar 11, 2026
8-K Current report
Other events
Mar 6, 2026 Mar 6, 2026
8-K Current report
Officer or director change
Mar 6, 2026 Feb 28, 2026
8-K Current report
Officer or director change
Nov 18, 2025 Oct 8, 2025
8-K Current report
Other events
Oct 2, 2025 Sep 26, 2025
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
Sep 29, 2025 Sep 24, 2025

Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Blank Checks (SIC 6770)
Listed as
DMII (Nasdaq), DMIIR (Nasdaq), DMIIU (Nasdaq)
Fiscal year ends
December 31
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2040475

Other Blank Checks companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.